15 Frequently Asked Questions : Leukemia, Lymphoma and Blood Cancer Treatments in India for Canadian Patients

Q1 · Why Do Canadian Patients Consider Leukemia, Lymphoma and Blood Cancer Treatment in India?

Canadian patients may consider India when they are looking for specialist evaluation, treatment options, second opinions or access to specialised haemato-oncology and transplant programmes.

Potential reasons include:

• Access to specialised haematologists and haemato-oncologists
• Multidisciplinary cancer treatment
• Chemotherapy and targeted treatment
• Immunotherapy and selected cellular therapies
• Bone marrow and stem cell transplantation
• CAR-T cell therapy at selected centres and for appropriate indications
• Advanced molecular and genetic testing
• Supportive treatment for complications of blood cancer
• Potentially lower treatment costs than some private international treatment settings
• Access to several major cancer centres in different Indian cities
• The possibility of coordinating diagnosis, specialist consultation and treatment within one healthcare system

However, the most important consideration is whether the proposed Indian treatment is medically appropriate for the patient's exact diagnosis and current disease status.

Canadian cancer information recognises chemotherapy, targeted therapy, radiation therapy, stem-cell transplantation and supportive care among the treatment approaches used for different types of leukemia.

Treatment is selected according to factors such as cancer type, age, genetic abnormalities, overall health and response to treatment.

Q2 · What Is the Cost of Leukemia, Lymphoma and Blood Cancer Treatment in India Compared with Canada?

Canadian patients should compare the complete treatment cost rather than looking only at the hospital or chemotherapy fee.

For Easy Comparison, Costs are mentioned in US Dollars (USD), Indian Rupees (INR) and Canadian Dollar (CAD).

These are planning exchange rates for comparison only. Actual currency conversion and hospital quotations can vary.

Exchange Rate Used for Planning

C$1 ≈ US$0.73  •  US$1 = INR 95

Important: Blood cancer treatment costs vary considerably. Drug selection, molecular testing, number of chemotherapy cycles, complications, hospitalisation, transplant type, donor requirements, cellular therapy and supportive care can substantially change the final cost.

These are indicative planning ranges and not fixed quotations. A personalised quotation should be obtained after review of the patient's medical records.

What Should Be Included in the Total Cost?

Canadian patients should ask whether the quotation includes:

• Haematologist/oncologist consultation
• Diagnostic investigations
• Blood tests and molecular/genetic testing
• Bone marrow examination
• Imaging where required
• Chemotherapy medicines
• Targeted medicines
• Immunotherapy
• Hospital admission
• ICU care if medically required
• Stem-cell collection
• Donor testing and HLA matching where applicable
• Transplant procedure
• CAR-T preparation and administration where applicable
• Blood and platelet support
• Antibiotics and other supportive medicines
• Doctor and specialist fees
• Nursing and monitoring
• Room and hospital charges
• Follow-up consultations
• Management of treatment-related complications
• Physiotherapy, nutrition and supportive rehabilitation where required
• Travel and accommodation
• Visa expenses
• Travel insurance and medical contingency expenses

Compare the Complete Treatment Cost

Treatment Journey in Canada

Diagnosis → Specialist consultation → Treatment planning → Chemotherapy / targeted treatment / immunotherapy / transplant where indicated → Monitoring → Follow-up

Treatment Journey in India

Medical records review → Specialist consultation → Diagnostic confirmation → Treatment planning → Treatment → Monitoring → Follow-up → Return to Canada

The final decision should consider medical suitability, treatment availability, specialist expertise, treatment duration, safety, follow-up arrangements and total cost.

Compare the full planned treatment journey, not only the surgery quotation.

Q3 · Which Indian Cities Are Best for Leukemia, Lymphoma and Blood Cancer Treatment for Canadian Patients?

The right Indian city depends on the patient's diagnosis, treatment requirements, haematologist, oncology team, transplant or cellular-therapy requirements, hospital infrastructure, rehabilitation and accessibility— not simply the lowest treatment cost.

The final city should be selected according to the patient's medical condition and the hospital and specialist

Q4 · Which Hospitals in India Treat Leukemia, Lymphoma and Blood Cancers?

Canadian patients may consider hospitals with dedicated haematology, haemato-oncology, bone- marrow/stem-cell transplant and advanced cancer programmes.

Hospital choice should be based on the patient's exact diagnosis and required treatment rather than hospital name alone.

Q5 · What Types of Leukemia, Lymphoma and Blood Cancer Treatments Are Available in India?

Treatment depends on the specific blood cancer and its biological characteristics.

Leukemia Major types include:

• Acute Lymphoblastic Leukemia (ALL)
• Acute Myeloid Leukemia (AML)
• Chronic Lymphocytic Leukemia (CLL)
• Chronic Myeloid Leukemia (CML)

Treatment may include

• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiation therapy in selected situations
• Stem cell transplantation
• Supportive treatment
• Cellular therapies for selected patients

Lymphoma

Treatment may include

• Chemotherapy
• Immunotherapy
• Targeted therapy
• Radiation therapy
• Stem cell transplantation
• Cellular therapy for selected relapsed or refractory disease
• Supportive care

Multiple Myeloma and Other Blood Cancers

Depending on the diagnosis, treatment may include:

• Combination drug therapy
• Targeted treatment
• Immunotherapy
• Stem cell transplantation
• Maintenance therapy
• Supportive treatment
• Selected cellular therapies

The Canadian Cancer Society notes that chemotherapy may be the main treatment for many leukemias, while targeted therapy, radiation, stem-cell transplantation and supportive treatment may be used according to the disease and individual patient factors.

Q6 · How Can Canadian Patients Get a Blood Cancer Treatment Quotation From India While Abroad?

Patients can generally begin the process before travelling by providing their complete medical records for specialist review.

Recommended Medical Documents

• Recent haematology reports
• Complete blood count reports
• Peripheral blood smear
• Bone marrow biopsy/aspiration reports
• Flow cytometry reports
• Cytogenetic and molecular/genetic reports
• PET-CT/CT/MRI reports where applicable
• Pathology reports
• Previous biopsy reports
• Previous chemotherapy details
• Previous transplant records
• Medication list
• Discharge summaries
• Current treatment plan
• Doctor's referral or clinical summary

The Indian specialist can then assess:

• Diagnosis
• Disease subtype
• Disease status
• Previous treatment
• Treatment response
• Current health status
• Possible treatment options
• Need for transplant or cellular therapy
• Expected hospitalisation
• Estimated treatment cost

A final treatment plan should be confirmed after appropriate specialist evaluation.

Q7 · Can Canadian Patients Get a Second Opinion From an Indian Blood Cancer Specialist?

Yes. A second opinion can be particularly useful when:

• The diagnosis is complex
• The patient has relapsed disease
• The cancer has not responded adequately to treatment
• A stem-cell transplant has been suggested
• CAR-T or another cellular therapy is being considered
• There are different treatment options
• The patient wants to understand targeted or immunotherapy options
• The pathology or molecular findings need specialist review

A second opinion should be based on complete medical records, pathology, molecular testing and previous treatment history.

Patients should not stop or change active cancer treatment solely on the basis of an online or remote opinion without discussing the decision with their treating medical team.

Q8 · What Records, Tests and Treatment Information Should Canadian Patients Take Home From India?

Patients should maintain a complete copy of their treatment records for continuity of care in Canada.

Ask for:

• Final diagnosis
• Pathology reports
• Bone marrow reports
• Flow cytometry reports
• Cytogenetic/molecular test results
• Imaging reports and images
• Treatment protocols
• Chemotherapy drug names and doses
• Targeted therapy details
• Immunotherapy details
• Transplant documentation
• Donor/HLA information where applicable
• CAR-T documentation where applicable
• Blood transfusion records
• Medication list
• Discharge summary
• Complication records
• Follow-up recommendations
• Future testing schedule
• Specialist contact information
• Copies of important laboratory results

This information can help the patient's Canadian healthcare team continue treatment and follow-up after returning home.

Q9 · Are Advanced, Targeted, Immunotherapy, Stem Cell and CAR-T Treatments Available in India?

Selected Indian centres provide advanced treatments for blood cancers, but eligibility varies substantially by diagnosis.

Targeted Therapy

Targeted medicines may be used when a patient's leukemia or lymphoma has a particular molecular or biological characteristic.

Immunotherapy Immunotherapy may include antibody-based treatments and other immune-directed approaches, depending on the cancer.

Stem Cell / Bone Marrow Transplant

Stem-cell transplantation is an important treatment option for selected patients with leukemia, lymphoma and other blood cancers. It may involve the patient's own stem cells or donor stem cells depending on the disease and clinical situation.

CAR-T Cell Therapy

CAR-T is a specialised cellular therapy in which immune cells are modified to recognise and attack specific cancer cells. It is used for selected blood cancers, particularly certain relapsed or refractory diseases.

India has developed and introduced CAR-T programmes, including indigenous CAR-T technology for selected B-cell blood cancers.

Patients should confirm:

• Whether CAR-T is approved/available for their exact indication
• Eligibility criteria
• Previous treatments required
• Cell collection requirements
• Manufacturing timeline
• Hospitalisation requirements
• Potential complications
• Total treatment cost
• Long-term follow-up arrangements

Q10 · Does Canadian Healthcare or Travel Insurance Cover Blood Cancer Treatment in India?

Canadian patients should not assume that planned treatment overseas will be reimbursed by provincial or territorial healthcare plans.

Coverage rules can vary according to the province or territory, the treatment, medical necessity and whether prior approval is required.

Before travelling, patients should separately check:

Canadian Healthcare Coverage

Ask whether any part of planned treatment outside Canada is eligible for reimbursement or prior approval.

Travel Insurance

Check whether the policy covers:

• Pre-existing conditions
• Planned medical treatment overseas
• Cancer-related complications
• Emergency hospitalisation
• Medical evacuation
• Repatriation
• Additional accommodation
• Flight changes

Many travel insurance policies have exclusions or limitations relating to planned medical treatment and pre- existing conditions.

Unexpected Medical Costs

Patients should also budget for:

• Additional hospitalisation
• ICU care
• Infection management
• Blood or platelet transfusions
• Treatment complications
• Additional investigations
• Additional chemotherapy
• Extended accommodation
• Delayed return travel

Q11 · Can Leukemia, Lymphoma or Blood Cancer Treatment Be Combined or Staged During One Trip?

Sometimes treatment can be organised in stages, but blood cancer treatment is generally not a simple one-visit procedure.

A possible treatment journey may include:

Initial consultation → Diagnostic review → Additional testing → Treatment planning → Chemotherapy / targeted treatment / immunotherapy → Response assessment → Further treatment → Transplant or cellular therapy if indicated → Recovery → Follow-up

For stem-cell transplantation or CAR-T therapy, the patient may need to remain near the treating hospital for an extended period because monitoring and management of complications can be intensive.

Canadian patients should ask the treating centre:

• How long will the initial evaluation take?
• How many treatment cycles are expected?
• Is hospitalisation required?
• How long is the expected stay after transplant?
• Is a caregiver required?
• When is it medically safe to travel?
• Can some follow-up occur in Canada?
• What tests must be completed before returning home?

Q12 · What About Medical Visa, Flights and Hospital Admission for Blood Cancer Treatment in India?

Canadian patients travelling to India for planned medical treatment should arrange the appropriate medical travel documentation and visa requirements before departure.

Before Travel

Prepare

• Passport
• Appropriate medical visa documentation
• Hospital appointment/acceptance documents
• Medical reports
• Treatment summary
• Medication list
• Travel insurance information
• Emergency contact details
• Accommodation details
• Copies of all important medical records

Flights Patients undergoing intensive chemotherapy, transplant or cellular therapy should discuss travel timing with their treating specialist.

Depending on blood counts, infection risk and treatment stage, flying may not be appropriate at certain times.

Hospital Admission

The hospital may arrange:

• Initial consultation
• Diagnostic testing
• Admission where required
• Treatment scheduling
• Specialist consultations
• Treatment monitoring
• Discharge planning

The treating hospital should confirm the patient's expected admission date and required documents before travel.

Q13 · How Long Should Canadian Patients Stay in India and When Can They Fly Home?

The duration varies significantly according to the diagnosis and treatment.

Consultation and Diagnostic Evaluation

A relatively short visit may be possible when the purpose is only consultation and second opinion.

Chemotherapy Patients may need repeated visits or an extended stay depending on the treatment schedule.

Stem Cell Transplant

A transplant usually requires a significantly longer period of close medical monitoring because of infection, blood-count and other potential complications. Stem-cell transplantation is a complex treatment that should be performed at a specialised centre.

CAR-T Therapy

CAR-T treatment may require cell collection, manufacturing/processing time, conditioning treatment, infusion and close monitoring afterwards.

Patients should not book a fixed return flight until their treating team confirms that they are medically fit to travel.

Before flying home, ask the doctor about:

• Blood counts
• Infection risk
• Medication requirements
• Need for transfusions
• Recent complications
• Follow-up testing
• Fitness to fly
• Airline requirements
• Emergency precautions during travel

Q14 · What Rehabilitation and Follow-Up Care Will Canadian Patients Need After Returning Home?

Follow-up depends on the specific blood cancer and treatment received.

Patients returning to Canada should carry a detailed treatment summary for their Canadian haematologist/ oncologist.

Follow-up may include

• Blood counts
• Bone marrow testing
• Molecular monitoring
• Imaging where required
• Medication management
• Infection monitoring
• Nutritional support
• Physiotherapy when required
• Fatigue management
• Psychological and emotional support
• Monitoring for treatment-related complications
• Long-term cancer surveillance

After stem-cell transplantation, follow-up can be particularly important because complications may occur during recovery and later periods.

Patients should arrange their Canadian follow-up before leaving India whenever possible.

Q15 · Should Canadian Patients Choose Blood Cancer Treatment in Canada or India?

There is no single answer that is right for every patient.

Canada May Be Preferable When

• The required treatment is readily available
• The patient has an established specialist team
• Long-term monitoring is the priority
• The treatment is covered or substantially supported by the patient's healthcare system
• The patient has complex ongoing medical needs
• Travel would create additional medical risk

India May Be Considered When

• The patient wants an additional specialist opinion
• A particular treatment or specialist programme is being considered
• The patient is exploring transplant or cellular-therapy options
• A multidisciplinary evaluation is desired
• Treatment costs and waiting times are important considerations
• The patient wants to compare treatment options internationally

Before Making the Final Decision

Canadian patients should compare:

• Exact diagnosis
• Treatment recommendation
• Specialist expertise
• Hospital infrastructure
• Transplant facilities
• Cellular-therapy availability where relevant
• Expected treatment duration
• Expected hospital stay
• Treatment risks
• Follow-up arrangements
• Total treatment cost
• Insurance coverage
• Travel requirements
• Emergency arrangements
• Long-term continuity of care

The best destination is the one that provides an appropriate, safe and medically justified treatment plan for the individual patient.